Cite
HARVARD Citation
Pascual-Pasto, G. et al. (2022). GPC2 antibody–drug conjugate reprograms the neuroblastoma immune milieu to enhance macrophage-driven therapies. Journal for immunotherapy of cancer. 10 (12), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Pascual-Pasto, G. et al. (2022). GPC2 antibody–drug conjugate reprograms the neuroblastoma immune milieu to enhance macrophage-driven therapies. Journal for immunotherapy of cancer. 10 (12), p. . [Online].